8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Stryker reports 7.7% third-quarter sales growth and raises buyback authorization
Filed with the SEC on · Summarized by InvestorsBot
Stryker’s third-quarter 2026 net sales rose 7.7% to $6.52 billion, while adjusted EPS increased 10.3% to $3.52; reported EPS fell 11.7% to $1.96, partly reflecting a $293 million goodwill impairment and other special items. The company repurchased $1.0 billion of stock in the quarter and increased its existing repurchase authorization by $3.0 billion in October, while updating full-year guidance to 6.5%-7.0% organic sales growth and adjusted EPS of $14.80-$14.90.